{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:29:55Z","timestamp":1787851795172,"version":"build-2784847793"},"reference-count":10,"publisher":"Centers for Disease Control MMWR Office","issue":"33","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Morb. Mortal. Wkly. Rep."],"DOI":"10.15585\/mmwr.mm7533a2","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T10:54:16Z","timestamp":1787828056000},"page":"522-528","source":"Crossref","is-referenced-by-count":0,"title":["Buprenorphine Dispensed by Pharmacies and Administered in Emergency Departments in Urban and Rural Areas \u2014 United States, 2019\u20132025"],"prefix":"10.15585","volume":"75","author":[{"suffix":"Jr.","given":"Gery P.","family":"Guy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Nataraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macarena C.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Dowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Baldwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"key-10.15585\/mmwr.mm7533a2-202608271312-R1","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1111\/add.14991","article-title":"Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services.","volume":"115","author":"Krawczyk","year":"2020","journal-title":"Addiction"},{"key":"key-10.15585\/mmwr.mm7533a2-202608271312-R2","doi-asserted-by":"publisher","first-page":"567","DOI":"10.15585\/mmwr.mm7325a1","article-title":"Treatment for opioid use disorder: population estimates\u2014United States, 2022.","volume":"73","author":"Dowell","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm7533a2-202608271312-R3","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/adm.0000000000001457","article-title":"Individuals dispensed buprenorphine in the US before and after federal policy changes aimed at increasing access.","volume":"19","author":"Guy","year":"2025","journal-title":"J Addict Med"},{"key":"key-10.15585\/mmwr.mm7533a2-202608271312-R4","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/adm.0000000000001402","article-title":"Buprenorphine administration and prescribing at emergency departments: a national analysis from 2014\u20132021.","volume":"19","author":"Ramdin","year":"2025","journal-title":"J Addict Med"},{"key":"key-10.15585\/mmwr.mm7533a2-202608271312-R5","first-page":"224","article-title":"Access to medication-assisted treatment in the United States: comparison of travel time to opioid treatment programs and office-based buprenorphine treatment.","volume":"1","author":"Amiri","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"key-10.15585\/mmwr.mm7533a2-202608271312-R6","doi-asserted-by":"publisher","first-page":"104805","DOI":"10.1016\/j.drugpo.2025.104805","article-title":"Barriers to accessing medications for opioid use disorder among rural individuals.","volume":"140","author":"Morenz","year":"2025","journal-title":"Int J Drug Policy"},{"key":"key-10.15585\/mmwr.mm7533a2-202608271312-R7","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1377\/hlthaff.2025.00191","article-title":"State laws prohibiting prior authorization for medications for opioid use disorder in private insurance, 2015\u20132023.","volume":"44","author":"Hu","year":"2025","journal-title":"Health Aff (Millwood)"},{"key":"key-10.15585\/mmwr.mm7533a2-202608271312-R8","doi-asserted-by":"publisher","first-page":"e231572","DOI":"10.1001\/jamanetworkopen.2023.1572","article-title":"High-dose buprenorphine initiation in the emergency department among patients using fentanyl and other opioids.","volume":"6","author":"Snyder","year":"2023","journal-title":"JAMA Netw Open"},{"key":"key-10.15585\/mmwr.mm7533a2-202608271312-R9","doi-asserted-by":"publisher","first-page":"4090","DOI":"10.1007\/s11606-025-09655-8","article-title":"Prescriber-level changes in buprenorphine dispensing in the USA before and after federal policy changes aimed at increasing prescribing.","volume":"40","author":"Guy","year":"2025","journal-title":"J Gen Intern Med"},{"key":"key-10.15585\/mmwr.mm7533a2-202608271312-R10","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.annemergmed.2021.04.023","article-title":"Consensus recommendations on the treatment of opioid use disorder in the emergency department.","volume":"78","author":"Hawk","year":"2021","journal-title":"Ann Emerg Med"}],"container-title":["MMWR. Morbidity and Mortality Weekly Report"],"original-title":[],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:13:16Z","timestamp":1787850796000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/75\/wr\/mm7533a2.htm?s_cid=mm7533a2_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":10,"journal-issue":{"issue":"33","published-online":{"date-parts":[[2026,8,27]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.mm7533a2","relation":{},"ISSN":["0149-2195","1545-861X"],"issn-type":[{"value":"0149-2195","type":"print"},{"value":"1545-861X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8,27]]},"published":{"date-parts":[[2026,8,27]]}}}